In a report released today, Steven Halper from Cantor Fitzgerald maintained a Buy rating on UnitedHealth (NYSE: UNH), with a price target of $300. The company’s shares opened today at $261.59, close to its 52-week high of $263.02.
Halper noted:
“We rate the shares of UnitedHealth Group (UNH) Overweight. Our 12-month DCF-based price target is $300. The company is nicely diversified within its UnitedHealthcare (UHC) health insurance segment. The reduction in losses relating to individual exchange plans should help UNH post solid bottom-line growth in 2018. UNH is unique within our coverage universe given its Optum segment, which accounted for 44% of consolidated operating profit in 2017. We expect continued strong growth in Optum in 2018. We continue to believe that UNH should be a core holding in all large-cap growth portfolios.”
According to TipRanks.com, Halper is a top 100 analyst with an average return of 22.2% and a 75.9% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.
UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $286.33.
See today’s analyst top recommended stocks >>
UnitedHealth’s market cap is currently $249B and has a P/E ratio of 21.55. The company has a Price to Book ratio of 5.24.
Based on the recent corporate insider activity of 182 insiders, corporate insider sentiment is negative on the stock. Earlier this month, William C. Ballard, a Director at UNH sold 10,000 shares for a total of $2,588,300.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
